The novel demonstration of this reduction of toxic tau species in the hTau mice, combined with the decrease of synaptic Aβ pathology in the Aβ/tau co-expressing 3xTgAD mice, further support the effectiveness of NIR light as a non-invasive treatment to reduce AD-related neuropathology and encourages its future clinical development. Here, MAPT is linked to Alzheimer disease.